UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 10,369	$ 15,162
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	526	577
Amortization	4,512	1,663
Gain on Investments	0	(32)
Provision for (recovery of) losses on accounts receivable	(2)	(1)
Amortization of Right of Use Assets	29	0
(Gain) loss on disposal of assets	0	(409)
Deferred income taxes	(398)	(352)
Stock-based compensation expense	85	53
Tax benefit attributable to exercise of stock options	20	44
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(1,139)	(948)
Inventories	(1,449)	255
Prepaid expenses and other current assets	73	52
Accounts payable	(188)	(258)
Accrued expenses	(1,023)	(3,455)
Total adjustments	1,046	(2,811)
Net cash provided by operating activities	11,415	12,351
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(252)	(255)
Intangible assets	(21,000)	0
Purchases of investments	0	0
Proceeds from sale of investments	0	74
Proceeds from sale of property and equipment	0	862
Net cash (used in) provided by investing activities	(21,252)	681
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	223	436
Common stock purchased and retired	(398)	0
Payment of dividends	(3,083)	(3,018)
Net cash used in financing activities	(3,258)	(2,582)
Effect of exchange rate changes on cash	(624)	(973)
Net increase (decrease) in cash and cash equivalents	(13,719)	9,477
Cash at beginning of period	51,112	39,875
Cash at end of period	37,393	49,352
Cash paid during the period for income taxes	3,957	3,820
Cash paid during the period for interest	$ 0	$ 0